A mAb2™ is a full-length antibody with an Fcab™ in place of the normal Fc region. With these additional binding sites, mAb2 bispecific monoclonal antibodies can bind two different targets at the same time.
mAb2™ bispecific monoclonal antibodies maintain the full functionality, structural integrity, and stability of ordinary antibodies.
// mAb2™ - Genuine bispecific monoclonal antibodies
A mAb2™ (pronounced “mAb-square”) is a full-length antibody in which the normal Fc region has been replaced by an Fcab™. Thus, mAb2 bispecific monoclonal antibodies can bind two different antigens at the same time. In excess of 20 mAb2 have been successfully generated over the last 12 months.
F-star’s mAb2 bispecific antibody products:
- Look like monoclonal antibodies; comparable structure
- Work like monoclonal antibodies; retain all antibody functionality
- Behave like monoclonal antibodies; maintain manufacturing characteristics
- Perform beyond monoclonal antibodies; offering therapeutic synergy through bispecificity
Our Modular Antibody Technology™ platform creates virtually limitless product opportunities; and is unprecedented in the ease of development and manufacturing genuine bispecific antibody products.